Loading provider…
Loading provider…
Neurology Physician in Charlestown, MA
NPI: 1295148237Primary Employer
Massachusetts General Physicians Organization Inc
massgeneral.org
HQ Phone
Get MB BCH BAO MRCPI Grace's Phone Numberphone_androidMobile
Get MB BCH BAO MRCPI Grace's MobileLooking to connect with more Physicians?
Dmand AI gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Get Started for Freearrow_outwardMA State Medical License
| # | Procedure Code (CPT®/HCPCS II) | Procedure Patients | Procedure Volume |
|---|---|---|---|
| 1 | 99215Established patient office or other outpatient, visit typically 40 minutes | 89 | 165 |
| 2 | 99232Subsequent hospital inpatient care, typically 25 minutes per day | 24 | 28 |
| 3 | 99222Initial hospital care with straightforward or low-level medical decision making, if using time, at least 55 minutes | 20 | 20 |
| 4 | 99221Initial hospital inpatient care, typically 30 minutes per day | 14 | 14 |
| 5 | G2212Prolonged office or other outpatient evaluation and management service(s) beyond the maximum required time of the primary procedure which has been selected using total time on the date of the primary service; each additional 15 minutes by the physician or | 12 | 39 |
Higher urate in LRRK2 mutation carriers resistant to Parkinson disease.
Authors: Bakshi, Rachit, Macklin, Eric A, Logan, Robert, Zorlu, Musab M, Xia, Ning, Crotty, Grace F, Zhang, Ellen, Chen, Xiqun, Ascherio, Alberto, Schwarzschild, Michael A
Journal: Ann Neurol
Publication Date: 2019-03-03
If LRRK2 Set the Fire, Can Nonsteroidal Anti-inflammatory Drugs Wet the Flames?
Authors: Crotty, Grace F, Lo, Raymond Y, Schwarzschild, Michael A
Journal: Mov Disord
Perspectives of People At-Risk on Parkinson's Prevention Research.
Authors: Virginia Gao
Journal: J Parkinsons Dis
Lead Sponsor: Parkinson's Foundation
Collaborators: Indiana University, The Parkinson Study Group, Fulgent Laboratories, Navitas Clinical Research, Inc
Intervention / Treatment: DEVICE: Lab Assay for seven genetic variants for Parkinson's Disease